.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Covington
Mallinckrodt
Boehringer Ingelheim
QuintilesIMS
US Army
Novartis
Baxter
Merck
Chinese Patent Office

Generated: February 23, 2018

DrugPatentWatch Database Preview

Patents Expiring in November 2026

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Otsuka Pharm Co LtdABILIFY MYCITE KITaripiprazoleTABLET;ORAL207202-003Nov 13, 2017RXYesNo➤ Sign Up➤ Sign UpY
Pfizer IncLYRICA CRpregabalinTABLET, EXTENDED RELEASE;ORAL209501-001Oct 11, 2017RXYesNo➤ Sign Up➤ Sign UpY
Pfizer IncLYRICA CRpregabalinTABLET, EXTENDED RELEASE;ORAL209501-001Oct 11, 2017RXYesNo➤ Sign Up➤ Sign UpYTREATMENT OF NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY
Pfizer IncLYRICA CRpregabalinTABLET, EXTENDED RELEASE;ORAL209501-001Oct 11, 2017RXYesNo➤ Sign Up➤ Sign UpYTREATMENT OF POSTHERPETIC NEURALGIA
Otsuka Pharm Co LtdABILIFY MYCITE KITaripiprazoleTABLET;ORAL207202-002Nov 13, 2017RXYesYes➤ Sign Up➤ Sign UpY
Otsuka Pharm Co LtdABILIFY MYCITE KITaripiprazoleTABLET;ORAL207202-001Nov 13, 2017RXYesNo➤ Sign Up➤ Sign UpY
Pfizer IncLYRICA CRpregabalinTABLET, EXTENDED RELEASE;ORAL209501-003Oct 11, 2017RXYesYes➤ Sign Up➤ Sign UpY
Pfizer IncLYRICA CRpregabalinTABLET, EXTENDED RELEASE;ORAL209501-003Oct 11, 2017RXYesYes➤ Sign Up➤ Sign UpYTREATMENT OF POSTHERPETIC NEURALGIA
Pfizer IncLYRICA CRpregabalinTABLET, EXTENDED RELEASE;ORAL209501-003Oct 11, 2017RXYesYes➤ Sign Up➤ Sign UpYTREATMENT OF NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY
Otsuka Pharm Co LtdABILIFY MYCITE KITaripiprazoleTABLET;ORAL207202-006Nov 13, 2017RXYesNo➤ Sign Up➤ Sign UpY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Novartis
Argus Health
Chubb
Julphar
Citi
Fuji
Moodys
Medtronic
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot